MedTrace Logo

Trial Outcomes & Findings for CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma (NCT NCT00893516)

NCT ID: NCT00893516

Last Updated: 2024-04-09

Results Overview

All efforts to obtain data have been exhausted, therefore we have no data available to report.

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

5 participants

Results posted on

2024-04-09

Participant Flow

All efforts to obtain data have been exhausted, therefore we have no data available to report.

Participant milestones

Participant milestones
Measure
1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4
CHOP chemo therapy + CD4 therapy CHOP + CD4
2 CHOP Chemotherapy CHOP
CHOP chemotherapy CHOP
Overall Study
STARTED
0
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Population: All efforts to obtain data have been exhausted, therefore we have no data available to report.

All efforts to obtain data have been exhausted, therefore we have no data available to report.

Outcome measures

Outcome data not reported

Adverse Events

1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

2 CHOP Chemotherapy CHOP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Development Representative

Emergent Biosolutions

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place